Analysis of nearly 8,000 adults found 45% keep the weight off after one year As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings
Pragmatic decisions strike a balance between clinical practicality and biological efficacy
Counterfeit sleeping pills containing nitazines have caused a rash of overdoses in prisons in Ireland
Conclusion This exit interview study provides qualitative evidence to support the interpretation of the clinical trial findings for retatrutide in the treatment of obesity, with detailed descriptions from participants of positive experiences relating to weight loss, eating behaviors, physical aspects, emotions, and lifestyle
When you eat, your gut releases natural GLP-1
Patients may self inject at home, return weekly for in-office injections, or use oral medication when appropriate